| Serial Number | 98923826 |
| Word Mark | F FIERCE PHARMA |
| Filing Date | Thursday, December 26, 2024 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Wednesday, October 1, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Arranging and conducting in-person educational forums, educational meetings, conferences, and conventions in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; educational services, namely, arranging and conducting educational conferences, seminars and workshops in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing information and news in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing online, non-downloadable newsletters in the fields of pharmaceuticals, drug development, cell and gene therapy, drug manufacturing and drug regulations; conducting of business conferences in the field of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations |
| Description of Mark | The mark consists of a stylized "F" design next to the wording "FIERCE PHARMA". |
| Pseudo Mark | FIERCE FIERCE PHARMA |
| Goods and Services | Conducting, arranging, promoting and organizing trade shows, business expos and buyer events for business purposes in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing public policy information in the field of drugs |
| NOT AVAILABLE | "PHARMA" |
| Goods and Services | Providing medical and scientific research information and news in the fields of pharmaceuticals, drug development, cell and gene therapy, and drug manufacturing |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 11, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, June 5, 2020 |
| First Use In Commerce Date | Friday, June 5, 2020 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 11, 2025 |
| Primary Code | 041 |
| First Use Anywhere Date | Friday, June 5, 2020 |
| First Use In Commerce Date | Friday, June 5, 2020 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 11, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, June 5, 2020 |
| First Use In Commerce Date | Friday, June 5, 2020 |
| Party Name | Questex, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | New York, NY 10017 |
| Event Date | Event Description |
| Thursday, December 26, 2024 | NEW APPLICATION ENTERED |
| Tuesday, May 27, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, May 27, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 5, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, June 11, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 11, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, September 11, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 22, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, September 22, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, June 11, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, September 11, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 11, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 22, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Monday, September 22, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, October 1, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |